It has been often observed that the chemotherapeutic armamentarium against an important disease such as schistosomiasis consists of just one drug, praziquantel. Thus, development of drug resistance is an impending danger, with serious implications for the health protection of many millions of people. This rational and legitimate concern might now begin to be relieved by the recent proposal of a new class of compounds that could represent a novel source of drugs against schistosomiasis. © 2008 Elsevier Ltd. All rights reserved.
Will new antischistosomal drugs finally emerge? / Donato, Cioli; Cristiana, Valle; Angelucci, Francesco; Miele, Adriana Erica. - In: TRENDS IN PARASITOLOGY. - ISSN 1471-4922. - STAMPA. - 24:9(2008), pp. 379-382. [10.1016/j.pt.2008.05.006]
Will new antischistosomal drugs finally emerge?
ANGELUCCI, Francesco;MIELE, Adriana Erica
2008
Abstract
It has been often observed that the chemotherapeutic armamentarium against an important disease such as schistosomiasis consists of just one drug, praziquantel. Thus, development of drug resistance is an impending danger, with serious implications for the health protection of many millions of people. This rational and legitimate concern might now begin to be relieved by the recent proposal of a new class of compounds that could represent a novel source of drugs against schistosomiasis. © 2008 Elsevier Ltd. All rights reserved.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
